Although macrophage insulin signaling is impaired in cardiometabolic disease (obesity and T2D, atherosclerosis, and heart failure), insulin-resistant macrophages have increased glucose uptake, glycolysis, and glucose oxidation. Here, INS is linked to type 2 diabetes mellitus.